Clinical Trial Update: Paricalcitol Over Inflammatory Parameters on Chronical Kidney Disease Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial updating paricalcitol's effect on inflammatory parameters in patients with chronic kidney disease and completed status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Paricalcitol (paricalcitol)

Snippet

Sponsor: Ricardo Mouzo Mirco | Conditions: Chronic Kidney Disease | Phase 3 | Status: COMPLETED